ConductScience.org, home

Paper36746385

The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy.

Lee JS and 10 others. J Stroke, 2023. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy. Papers, record 36746385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36746385

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy.
PubMed
Journal
J Stroke
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2023-02-17
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee JSJin Soo
2Lee JSJi Sung
3Gwag BJByoung Joo
4Choi DWDennis W
5An CSChun San
6Kang HGHyun Goo
7Song TJTae-Jin
8Ahn SHSeong Hwan
9Kim CHChang Hun
10Shin DIDong-Ick
11Kwon SUSun U

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GNT pharmaPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05041010Rescues On Reperfusion Damage In Cerebral Infarction by NelonemdazDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121152450Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke.Drug News Perspect2010https://conductscience.org/library/papers/21152450PubMed
233765729Factors Contributing to an Efficacious Endovascular Treatment for Acute Ischemic Stroke in Asian Population.Neurointervention2021https://conductscience.org/library/papers/33765729PubMed
322394615Neuroprotection for ischaemic stroke: translation from the bench to the bedside.Int J Stroke2012https://conductscience.org/library/papers/22394615PubMed
417106444Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine.J Cereb Blood Flow Metab2007https://conductscience.org/library/papers/17106444PubMed
525517348A randomized trial of intraarterial treatment for acute ischemic stroke.N Engl J Med2015https://conductscience.org/library/papers/25517348PubMed
625671798Randomized assessment of rapid endovascular treatment of ischemic stroke.N Engl J Med2015https://conductscience.org/library/papers/25671798PubMed
736065810Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial.Stroke2022https://conductscience.org/library/papers/36065810PubMed
88577361Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro.Neuroscience1995https://conductscience.org/library/papers/8577361PubMed
910657404Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist.Stroke2000https://conductscience.org/library/papers/10657404PubMed
1033192266Excitotoxicity: Still Hammering the Ischemic Brain in 2020.Front Neurosci2020https://conductscience.org/library/papers/33192266PubMed
1121372310Barthel index for stroke trials: development, properties, and application.Stroke2011https://conductscience.org/library/papers/21372310PubMed
1215842354Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.J Thromb Haemost2005https://conductscience.org/library/papers/15842354PubMed
1317272767Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.Stroke2007https://conductscience.org/library/papers/17272767PubMed
1411730442Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.JAMA2001https://conductscience.org/library/papers/11730442PubMed
1510441299Pathobiology of ischaemic stroke: an integrated view.Trends Neurosci1999https://conductscience.org/library/papers/10441299PubMed
1612849400Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?Lancet Neurol2002https://conductscience.org/library/papers/12849400PubMed
1732087818Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.Lancet2020https://conductscience.org/library/papers/32087818PubMed
1825882376Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.N Engl J Med2015https://conductscience.org/library/papers/25882376PubMed
1929535893Temporal Changes in Care Processes and Outcomes for Endovascular Treatment of Acute Ischemic Stroke: Retrospective Registry Data from Three Korean Centers.Neurointervention2018https://conductscience.org/library/papers/29535893PubMed
2023268106Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage.Toxicol In Vitro2013https://conductscience.org/library/papers/23268106PubMed

See all 29 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42864556Long-Term Quantitative MRI and Quality-of-Life After Endovascular Therapy in Acute Ischemic Stroke - A MR CLEAN-NO IV Substudy.Transl Stroke Res2026https://conductscience.org/library/papers/42864556PubMed
41188625New advances in small molecule drugs targeting NMDA receptors.Acta Pharmacol Sin2026https://conductscience.org/library/papers/41188625PubMed
40842809Neuroprotective Agents With Reperfusion Therapies in Ischemic Stroke: Evidence From Recent Randomized Trials.Cureus2025https://conductscience.org/library/papers/40842809PubMed
40533350Can CTA-Based Machine Learning Identify Patients for Whom Successful Endovascular Stroke Therapy Is Insufficient?AJNR Am J Neuroradiol2025https://conductscience.org/library/papers/40533350PubMed
40494590Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke.J Stroke2025https://conductscience.org/library/papers/40494590PubMed
40325933In search of real-world cerebroprotection: An institutional perspective and review of the literature.Interv Neuroradiol2025https://conductscience.org/library/papers/40325933PubMed
39874036Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical Trial.JAMA Netw Open2025https://conductscience.org/library/papers/39874036PubMed
39684478The Therapeutic Effects of SP-8356, a Verbenone Derivative, with Multimodal Cytoprotective Mechanisms in an Ischemic Stroke Rat Model.Int J Mol Sci2024https://conductscience.org/library/papers/39684478PubMed
38733445Insight into the pathophysiological advances and molecular mechanisms underlying cerebral stroke: current status.Mol Biol Rep2024https://conductscience.org/library/papers/38733445PubMed
38662299Excitotoxic Storms of Ischemic Stroke: A Non-neuronal Perspective.Mol Neurobiol2024https://conductscience.org/library/papers/38662299PubMed
38255965Neuroprotection during Thrombectomy for Acute Ischemic Stroke: A Review of Future Therapies.Int J Mol Sci2024https://conductscience.org/library/papers/38255965PubMed
37959180Evolving Clinical-Translational Investigations of Cerebroprotection in Ischemic Stroke.J Clin Med2023https://conductscience.org/library/papers/37959180PubMed
36901765Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.Int J Mol Sci2023https://conductscience.org/library/papers/36901765PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DLG41742PubTator's text mininghttps://conductscience.org/library/genes/1742NCBI Gene
GRIN2A2903PubTator's text mininghttps://conductscience.org/library/genes/2903NCBI Gene
GRIN2B2904PubTator's text mininghttps://conductscience.org/library/genes/2904NCBI Gene
NOS14842PubTator's text mininghttps://conductscience.org/library/genes/4842NCBI Gene
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene
TAT6898PubTator's text mininghttps://conductscience.org/library/genes/6898NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36746385

GET https://conductscience.org/api/papers/v1/36746385/references?page=2